| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/14/2013 | CN101686972B Therapeutic compositions and the method thereof |
| 08/14/2013 | CN101654475B Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/14/2013 | CN101646656B Pyrimidine hydrazide compounds as PGDS inhibitors |
| 08/14/2013 | CN101641011B Method for treating and preventing arthritis |
| 08/14/2013 | CN101500576B Agents for preventing and treating disorders involving modulation of the RYR receptors |
| 08/14/2013 | CN101490038B Pyrimidine derivatives as ALK-5 inhibitors |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/14/2013 | CN101467985B Bisoprolol fumarate dispersible tablet and preparation method thereof |
| 08/14/2013 | CN101460495B Compound having heterocyclic ring |
| 08/14/2013 | CN101421282B Treatment of hyperproliferative diseases with vinca alkaloidn-oxide and analogs |
| 08/14/2013 | CN101407505B Method for preparing antivirus andrographolide derivative |
| 08/14/2013 | CN101390867B Compositions and methods for treatment of infection |
| 08/14/2013 | CN101341135B Substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| 08/14/2013 | CN101336077B Use of 25-hydroxy vitamin D3 to improve vitality of animals |
| 08/14/2013 | CN101331124B Novel vanilloid receptor ligands and their use for producing medicaments |
| 08/14/2013 | CN101316833B Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 08/14/2013 | CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine protease inhibitors and their therapeutic applications |
| 08/14/2013 | CN101227913B Self-gelling alginate systems and uses thereof |
| 08/14/2013 | CN101222856B Novel use of organic compounds |
| 08/14/2013 | CN101106986B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 08/13/2013 | USRE44437 Methods for detecting receptor complexes comprising PI3K |
| 08/13/2013 | US8507723 Polycationic compounds and uses thereof |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507710 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 08/13/2013 | US8507698 Artemisinin derivatives for the treatment of melanoma |
| 08/13/2013 | US8507690 Thiazole derivative and use thereof as VAP-1 inhibitor |
| 08/13/2013 | US8507687 Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/13/2013 | US8507684 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 08/13/2013 | US8507683 Compounds for the treatment of hepatitis C |
| 08/13/2013 | US8507681 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
| 08/13/2013 | US8507676 Heterocyclic oxime compounds |
| 08/13/2013 | US8507672 Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors |
| 08/13/2013 | US8507670 Matrix metalloproteinase inhibitors |
| 08/13/2013 | US8507661 Modified iRNA agents |
| 08/13/2013 | US8507658 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 08/13/2013 | US8507562 Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof |
| 08/13/2013 | US8507561 Desensitizing drug product |
| 08/13/2013 | US8507560 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| 08/13/2013 | US8507559 Cyclohexenyl modulators of chemokine receptor activity |
| 08/13/2013 | US8507558 Fatty acid treatment for cardiac patients |
| 08/13/2013 | US8507557 Potentiators of insulin secretion |
| 08/13/2013 | US8507556 Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity |
| 08/13/2013 | US8507555 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone |
| 08/13/2013 | US8507554 Quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist |
| 08/13/2013 | US8507553 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 08/13/2013 | US8507552 Triptolide prodrugs |
| 08/13/2013 | US8507551 Antimicrobial therapy for bacterial infections |
| 08/13/2013 | US8507550 Treatment for altitudinal hypoxia |
| 08/13/2013 | US8507549 Methods for synthesizing glycinols, glyceollins I and II and isoflavenes and chromanes using a Wittig reaction, and compositions made therewith |
| 08/13/2013 | US8507548 Method for treating addiction using quercetin-containing compositions |
| 08/13/2013 | US8507547 Anti-fatigue agents and oral compositions containing andrographolide as active ingredient |
| 08/13/2013 | US8507546 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| 08/13/2013 | US8507545 Cytotoxic T cell activator comprising EP4 agonist |
| 08/13/2013 | US8507544 Bi-aryl amide compounds as CRTh2 receptor modulators |
| 08/13/2013 | US8507543 Compounds |
| 08/13/2013 | US8507542 Methods of treating pediatric patients using dexmedetomidine |
| 08/13/2013 | US8507541 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 08/13/2013 | US8507540 Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same |
| 08/13/2013 | US8507539 Potassium channel blockers and uses thereof |
| 08/13/2013 | US8507538 Selective heterocyclic sphingosine 1 phosphate receptor modulators |
| 08/13/2013 | US8507537 Trifluromethoxyphenyl-substituted tetramic acid derivatives pesticides and/or herbicides |
| 08/13/2013 | US8507536 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/13/2013 | US8507535 Methyl-pyrrolidine ether derivatives |
| 08/13/2013 | US8507534 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/13/2013 | US8507533 Glucagon receptor modulators |
| 08/13/2013 | US8507532 Stable insecticide compositions and methods for producing same |
| 08/13/2013 | US8507531 Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer |
| 08/13/2013 | US8507530 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| 08/13/2013 | US8507529 Methods of using a nitroxide antioxidant in cosmetic and dermatological compositions |
| 08/13/2013 | US8507528 2-alkyl-indazole compounds for the treatment of certain cns-related disorders |
| 08/13/2013 | US8507526 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (IBS) |
| 08/13/2013 | US8507525 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 08/13/2013 | US8507524 Modulators of ATP-binding cassette-transporters |
| 08/13/2013 | US8507523 anticarcinogenic agents such as 6,7-dimethoxy-1-(4-pyridin-4-ylbenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride salt, used for treating gliomas or retinoblastomas; side effect reduction |
| 08/13/2013 | US8507522 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507521 Heterocyclic derivatives |
| 08/13/2013 | US8507520 Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof |
| 08/13/2013 | US8507519 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| 08/13/2013 | US8507518 Method of treating mantle cell lymphoma |
| 08/13/2013 | US8507517 Forms of rifaximin and uses thereof |
| 08/13/2013 | US8507516 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 08/13/2013 | US8507515 Crystalline form G of imatinib mesylate |
| 08/13/2013 | US8507513 Process for the preparation of rosuvastatin salts |
| 08/13/2013 | US8507512 Soluble guanylate cyclase activators |
| 08/13/2013 | US8507511 Inhibitors of protein kinases |
| 08/13/2013 | US8507510 Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents |
| 08/13/2013 | US8507509 Saturated and insaturated bi- or tricyclic aryloxyacetamine derivatives and their use as fungicides |
| 08/13/2013 | US8507508 Solid forms of pemetrexed |
| 08/13/2013 | US8507507 Modulators of toll-like receptors |
| 08/13/2013 | US8507506 Theophylline derivative inhibits osteoporosis |
| 08/13/2013 | US8507505 Dihydropyrazolopyrimidinone derivative |
| 08/13/2013 | US8507504 Process for producing bicycloaniline derivatives |
| 08/13/2013 | US8507503 Thienopyrimidinedione derivatives as TRPA1 modulators |
| 08/13/2013 | US8507502 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
| 08/13/2013 | US8507501 Inhibitors of the BMP signaling pathway |
| 08/13/2013 | US8507499 Substituted indole/indazole-pyrimidinyl compounds |
| 08/13/2013 | US8507497 Capped pyrazinoylguanidine sodium channel blockers |
| 08/13/2013 | US8507496 Treatment of diseases |